Amgen backs a fresh raise for AI player GNS Healthcare; SQZ names Agarwal as new CMO
⇨ Amgen Ventures and Alexandria Real Estate Equities have chipped in a fresh $6 million to back GNS Healthcare, which has been developing platform machine learning tech aimed at matching the right drug for a particular patient. “We are witnessing an acceleration in the use of artificial intelligence and machine learning across all industries with GNS leading the way in the life sciences and healthcare industries with data from tens of millions of lives being processed by our platforms,” noted CEO Colin Hill.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.